Mumbai, Nov. 4 -- In a press release, the company said the promoter sold 16,20,987 shares worth Rs 45.74 crore and will infuse the entire amount back into the company on an interest-free basis. The funds are intended to ensure timely commencement of groundwork and construction for the upcoming R-32 facility.

The company clarified that the infusion would be made without any equity dilution.

Managing director and CEO Shazad Rustomji said the move demonstrates his personal commitment to advancing the company's self-reliance goals in the fluorochemicals manufacturing segment. This infusion ensures work on our R-32 project begins without delay, while maintaining our capital structure, he noted.

Stallion India Fluorochemicals is a specialize...